129 related articles for article (PubMed ID: 12217762)
1. Further study of the management of cervical adenocarcinoma in situ.
Kennedy AW; Biscotti CV
Gynecol Oncol; 2002 Sep; 86(3):361-4. PubMed ID: 12217762
[TBL] [Abstract][Full Text] [Related]
2. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma in situ of the uterine cervix: management and outcome.
Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
5. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
[TBL] [Abstract][Full Text] [Related]
6. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
7. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
8. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
Latif NA; Neubauer NL; Helenowski IB; Lurain JR
J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
10. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
[TBL] [Abstract][Full Text] [Related]
11. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
[TBL] [Abstract][Full Text] [Related]
12. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
Huang SS; Sui L; Chen LM; Zhang HW; Tao X
Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
[No Abstract] [Full Text] [Related]
13. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
15. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
16. [Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature].
Omnes S; Morice P; Camatte S; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Gynecol Obstet Fertil; 2003 Nov; 31(11):912-9. PubMed ID: 14623554
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
[TBL] [Abstract][Full Text] [Related]
18. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ.
Kietpeerakool C; Khunamornpong S; Srisomboon J; Kasunan A; Sribanditmongkol N; Siriaungkul S
Int J Gynaecol Obstet; 2012 Dec; 119(3):266-9. PubMed ID: 22939281
[TBL] [Abstract][Full Text] [Related]
20. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.
McHale MT; Le TD; Burger RA; Gu M; Rutgers JL; Monk BJ
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):726-31. PubMed ID: 11704160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
